Encorafenib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Encorafenib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Encorafenib included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 66% Regorafenib
- 61% Oxaliplatin
- 61% Cetuximab
- 57% Nintedanib
- 50% Irinotecan
- 50% Panitumumab
- 50% Erlotinib
- 49% Trametinib
- 48% Capecitabine
- 46% Folinic acid
- 45% Lorlatinib
- 45% Selpercatinib
- 44% Sunitinib
- 44% Ramucirumab
- 43% Alectinib
- 41% Binimetinib
- 39% Nimustine
- 38% Calcium folinate
- 38% Tegafur+Gimeracil+Oteracil [Tegafur]
- 36% Lomustine
- 35% Osimertinib
- 35% Ceritinib
- 35% Capmatinib
- 35% Afatinib
- 34% Cabozantinib
- 34% Pazopanib
- 34% Abemaciclib
- 33% Tegafur
- 33% Hydrazine sulfate
- 31% Axitinib
- 31% Palbociclib
- 31% Nivolumab
- 31% Trastuzumab deruxtecan
- 31% Zanubrutinib
- 30% Melphalan
- 30% Ibrutinib
- 29% Nitrosomethylurea
- 29% Chlorin E6
- 28% Dasatinib
- 28% Atezolizumab
- 28% Raltitrexed
- 28% Mitomycin
- 28% Bevacizumab
- 27% Imatinib
- 27% Gallium [67Ga] citrate
- 27% Vandetanib
- 27% Crizotinib
- 27% Capivasertib
- 26% Teniposide
- 26% Topotecan
Learn more about the selection of analogues
▶
- The drug has «Encorafenib» 51 analog by action, the most similar - Regorafenib .
- Medical online service has selected the best substitutes for Encorafenib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Encorafenib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.